行情

BNGO

BNGO

Bionano Genomics
NASDAQ

实时行情|Nasdaq Last Sale

1.130
+0.050
+4.62%
盘后: 1.090 -0.04 -3.53% 19:59 01/28 EST
开盘
1.050
昨收
1.080
最高
1.150
最低
1.050
成交量
82.21万
成交额
--
52周最高
6.24
52周最低
0.5000
市值
948.74万
市盈率(TTM)
-0.4192
分时
5日
1月
3月
1年
5年

分析师评级

2位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

BNGO 新闻

  • 美国三大科技巨头限制员工赴中国旅行
  • 新浪财经.51分钟前
  • 富士康:疫情不会影响苹果订单的完成 已有后备方案
  • 新浪财经综合.1小时前
  • 阿联酋发现新冠肺炎病例 患者来自武汉
  • 新浪财经.1小时前
  • 调查显示巴西市场人士持续下调今年通胀预期
  • 新华网.1小时前

更多

所属板块

先进医疗设备和技术
+0.92%
医疗设备和用品
+0.58%

热门股票

名称
价格
涨跌幅

BNGO 简况

Bionano Genomics, Inc. is a life sciences instrumentation company in the genome analysis space. The Company develops and markets the Saphyr system. The Company’s products include Sequencing for Discovery Research and Cytogenetics. Sequencing alone, however, is significantly limited due to its inability to reveal structural variations. Cytogenetics provide a clinical diagnosis, cytogenetic tests detect known variations that are linked to specific diseases or therapeutic responses. Saphyr system is platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. Sequencing for Discovery Research is primarily used to find single nucleotide variations responsible for disease or therapeutic response.
展开

Webull提供BioNano Genomics Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。